These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Finch JL, Tokumoto M, Nakamura H, Yao W, Shahnazari M, Lane N, Slatopolsky E. Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094 [Abstract] [Full Text] [Related]
9. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease. Torres PU. J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031 [Abstract] [Full Text] [Related]
10. [Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics)--effect on the set point of calcium-regulated PTH secretion]. Nagano N. Clin Calcium; 2005 Jan; 15(1):71-8. PubMed ID: 15632475 [Abstract] [Full Text] [Related]
11. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Nagano N. Pharmacol Ther; 2006 Mar; 109(3):339-65. PubMed ID: 16102839 [Abstract] [Full Text] [Related]
12. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E. Gut; 2001 Jun; 48(6):765-73. PubMed ID: 11358893 [Abstract] [Full Text] [Related]
13. Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels. Kawata T, Imanishi Y, Kobayashi K, Onoda N, Okuno S, Takemoto Y, Komo T, Tahara H, Wada M, Nagano N, Ishimura E, Miki T, Ishikawa T, Inaba M, Nishizawa Y. J Bone Miner Metab; 2006 Jun; 24(4):300-6. PubMed ID: 16816924 [Abstract] [Full Text] [Related]
14. Interaction of calcium and magnesium on gastric acid secretion and serum gastrin concentration in man. Christiansen J, Rehfeld JF, Stadil F. Gastroenterology; 1975 May; 68(5 Pt 1):1140-3. PubMed ID: 236210 [Abstract] [Full Text] [Related]
16. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. Nemeth EF, Heaton WH, Miller M, Fox J, Balandrin MF, Van Wagenen BC, Colloton M, Karbon W, Scherrer J, Shatzen E, Rishton G, Scully S, Qi M, Harris R, Lacey D, Martin D. J Pharmacol Exp Ther; 2004 Feb; 308(2):627-35. PubMed ID: 14593085 [Abstract] [Full Text] [Related]
17. Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. Fukagawa M, Yumita S, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S, KRN1493 study group. Nephrol Dial Transplant; 2008 Jan; 23(1):328-35. PubMed ID: 17717030 [Abstract] [Full Text] [Related]
18. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. Schmidt WE, Schenk S, Nustede R, Holst JJ, Fölsch UR, Creutzfeldt W. Gastroenterology; 1994 Dec; 107(6):1610-20. PubMed ID: 7958670 [Abstract] [Full Text] [Related]
19. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. J Clin Endocrinol Metab; 2003 Dec; 88(12):5644-9. PubMed ID: 14671147 [Abstract] [Full Text] [Related]
20. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB. Gut; 1993 Aug; 34(8):1032-7. PubMed ID: 8174948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]